Zevra Therapeutics (NASDAQ: ZVRA) revenue
Zevra Therapeutics reported revenue of $106.5m for fiscal 2025, 350.9% more than in fiscal 2024 ($23.6m).
Fiscal 2025 is the highest of the 8 fiscal years on record for Zevra Therapeutics. The biggest drop was in fiscal 2022, −64.5%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $106.5m | +350.9% | −$62.9m | −59.1% |
| 2024 | $23.6m | −14.0% | −$87.0m | −368.5% |
| 2023 | $27.5m | +170.3% | −$49.6m | −180.6% |
| 2022 | $10.2m | −64.5% | −$42.6m | −418.9% |
| 2021 | $28.7m | +115.6% | $7.7m | 27.0% |
| 2020 | $13.3m | +3.5% | −$5.6m | −42.2% |
| 2019 | $12.8m | — | −$20.3m | −158.4% |
| 2018 | $0.0m | — | −$55.9m | — |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Zevra Therapeutics revenue compared with its sector
By revenue for its latest fiscal year, Zevra Therapeutics ranks 282nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Zevra Therapeutics, 350.9%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 280th | UroGen Pharma | $109.8m | 21.4% |
| 281st | Century Therapeutics | $109.2m | 1,556.8% |
| 282nd | Zevra Therapeutics | $106.5m | 350.9% |
| 283rd | Zymeworks | $106.0m | 38.9% |
| 284th | Sanara Medtech | $103.1m | 19.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Zevra Therapeutics
- How much revenue did Zevra Therapeutics make in fiscal 2025?
- Zevra Therapeutics reported revenue of $106.5m for fiscal 2025, compared with $23.6m in fiscal 2024.
- What was the best year for revenue at Zevra Therapeutics?
- Of its last 8 fiscal years, fiscal 2025, with $106.5m.
- Where does Zevra Therapeutics rank in its sector by revenue?
- It ranks 282nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Zevra Therapeutics come from?
- From the annual report (Form 10-K) that Zevra Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Zevra Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on Zevra Therapeutics: the Zevra Therapeutics page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.